Erlotinib hydrochloride key intermediate preparation method

A technology of acetic acid and nitric acid, which is applied in the field of medicinal chemistry, can solve the problems of increased side reactions, reduced purity, and unsuitability for large-scale industrial production, and achieves the effects of reducing the generation of waste liquid, facilitating industrial production, and strong production operability

Active Publication Date: 2017-07-04
JIANGSU HANSOH PHARMA CO LTD
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When repeating this nitration method, find that this nitration condition is too strong and cause three comparatively serious problems, 1. because the amount of concentrated sulfuric acid is bigger, when concentrated sulfuric acid adds reaction solution, very easily cause raw material 3,4-bis(2-methoxy 2. The reaction temperature when nitric acid is added dropwise is difficult to control, and the temperature is very easy to rapidly rise to more than 100°C, causing a sharp increase in side

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Erlotinib hydrochloride key intermediate preparation method
  • Erlotinib hydrochloride key intermediate preparation method
  • Erlotinib hydrochloride key intermediate preparation method

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0024] Glacial acetic acid (70L), acetic anhydride (10L) and 3,4-bis(2-methoxyethoxy) ethyl benzoate (23kg, 77.1mol) were added in the 200L reactor, and nitric acid ( 12L, 269.85 mol). Another concentrated sulfuric acid (200 ml, 3.85 mol) was diluted in glacial acetic acid (2 L). After the nitric acid was added dropwise, the diluted concentrated sulfuric acid glacial acetic acid solution was slowly added dropwise to the reaction kettle, the dropping was completed, and the temperature was raised to 40° C. to react for 2 hours. After the reaction is completed, the reaction solution is cooled to 20° C., slowly poured into the mixed solution of ice water (80L) and dichloromethane (80L) under stirring, the dichloromethane layer of the lower layer is separated, and the water layer of the upper layer is added with dichloromethane. (80L) extracted once, the lower organic layer was released, and the organic phases were combined. The organic phase was washed successively with purified...

example 2

[0027] Glacial acetic acid (80L), acetic anhydride (15L) and 3,4-bis(2-methoxyethoxy) ethyl benzoate (27kg, 90.5mol) were added in the 200L reactor, and nitric acid ( 14L, 316.75 mol). Another concentrated sulfuric acid (10 ml, 0.18 mol) was diluted in glacial acetic acid (1 L). After the nitric acid was added dropwise, the diluted concentrated sulfuric acid glacial acetic acid solution was slowly added dropwise to the reaction kettle, the dropping was completed, and the temperature was raised to 40° C. to react for 2 hours. After the reaction is completed, the reaction solution is cooled to 20° C., slowly poured into the mixed solution of ice water (80L) and dichloromethane (80L) under stirring, the dichloromethane layer of the lower layer is separated, and the water layer of the upper layer is added with dichloromethane. (80L) extracted once, the lower organic layer was released, and the organic phases were combined. The organic phase was washed successively with purified ...

example 3

[0029]Add glacial acetic acid (80L), acetic anhydride (15L) and ethyl 3,4-bis(2-methoxyethoxy)benzoate (25kg, 83.8mol) into a 200L reactor, and slowly add nitric acid ( 13 L, 293.3 mol). Another concentrated sulfuric acid (460ml, 8.4mol) was diluted in glacial acetic acid (1L). After the addition of nitric acid is completed, the diluted concentrated sulfuric acid solution in glacial acetic acid is slowly added dropwise to the reaction kettle. After the drop is complete, the temperature is raised to 40°C for 2 hours. After the reaction is complete, cool the reaction solution to 20°C, slowly pour it into a mixture of ice water (80L) and dichloromethane (80L) while stirring, separate the lower dichloromethane layer, and add dichloromethane to the upper water layer (80L) extracted once, the lower organic layer was released, and the organic phases were combined. The organic phase was washed successively with purified water (80 L), aqueous sodium bicarbonate (100 L), and saturated...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to an erlotinib hydrochloride key intermediate preparation method, particularly to a method for high reaction rate, high purity and high yield preparation of 2-nitro-4,5-bis(2-methoxyethoxy) ethyl benzoate from 3,4-bis(methoxyethoxy)ethyl benzoate, wherein in the presence of a catalytic amount of concentrated sulfuric acid, 3,4-bis(methoxyethoxy)ethyl benzoate and concentrated sulfuric acid are subjected to a reaction by using acetic acid and acetic anhydride as a solvent. According to the present invention, the method has characteristics of mild reaction condition, rapid reaction rate, high conversion rate, high product purity, safety and environmental protection, and is suitable for industrial production.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a preparation method of 2-nitro-4,5-bis(2-methoxyethoxy) ethyl benzoate, a key intermediate of erlotinib hydrochloride. Background technique [0002] Erlotinib Hydrochloride, trade name Tarceva, was developed by OSI Pharmaceuticals in the United States, and later approved by Roche Pharmaceuticals in November 2004, September 2005 and April 2006 in the United States, A tinib-type antitumor drug approved for marketing in Europe and China. As a small molecule compound, erlotinib hydrochloride belongs to the epidermal growth factor receptor (EGFR) family of tyrosine kinase inhibitors, and is suitable for locally advanced or metastatic non-small cell lung cancer after failure of at least one chemotherapy regimen in the past (NSCLC) treatment. Erlotinib hydrochloride is also a targeted drug preparation, which can target specific lesions and accumulate or release active ingredients a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C201/08C07C205/59
CPCC07C201/08C07C205/59
Inventor 陈绍磊张小兵季荣涛
Owner JIANGSU HANSOH PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap